Vycor Medical (VYCO) Return on Capital Employed Growth (1y) (2012 - 2026)
Vycor Medical (VYCO) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 125.00 |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | -259.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -259.00 |
| Dec 31, 2025 | -113.00 |
| Sep 30, 2025 | -493.00 |
| Jun 30, 2025 | -311.00 |
| Mar 31, 2025 | 26.00 |
| Dec 31, 2024 | 158.00 |
| Sep 30, 2024 | 306.00 |
| Jun 30, 2024 | 79.00 |
| Mar 31, 2024 | -742.00 |
| Dec 31, 2023 | -1,246.00 |
| Sep 30, 2023 | -1,452.00 |
| Jun 30, 2023 | -1,390.00 |
| Mar 31, 2023 | -416.00 |
| Dec 31, 2022 | -901.00 |
| Sep 30, 2022 | -764.00 |
| Jun 30, 2022 | -1,231.00 |
| Mar 31, 2022 | -2,696.00 |
| Dec 31, 2021 | -2,182.00 |
| Sep 30, 2021 | -1,808.00 |
| Jun 30, 2021 | -1,753.00 |